Literature DB >> 6947266

Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion.

N H Colburn, E J Wendel, G Abruzzo.   

Abstract

The JB-6 mouse epidermal cell line has been used as a model system for studying the mechanism of late-stage promoter-dependent preneoplastic progression. The studies reported here are concerned with determining whether there is a requirement for mitogenic stimulation in promotion of anchorage independence and tumorigenicity in JB-6 cells. Such a requirement would predict that variants selected for 12-O-tetradecanoylphorbol 13-acetate (TPA) mitogen resistance would also be promotion resistant. Promotion-responsive cell lines have been selected for resistance to TPA-induced mitogenic stimulation at plateau density by cotreatment with colchicine and removal of mitogen-responsive colchicine-detached cells. The selected TPA-resistant population of cells showed a mitogenic response that was diminished by a factor of four but showed no diminution in the promotion-of-anchorage-independence response to TPA. Mitogen-resistant clonal lines derived from the selected population fell into three phenotypic classes when assayed in soft agar: (i) anchorage-independent transformants; (ii) variants resistant to promotion of anchorage independence by TPA; and (iii) variants sensitive to promotion by TPA. The existence of the latter class (i.e., the mitogen-resistant promotable variants) indicates a lack of obligatory causal relationship between TPa-induced mitogenesis and late-stage promotion and, thereby suggests that the two events can be dissociated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6947266      PMCID: PMC349162          DOI: 10.1073/pnas.78.11.6912

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism.

Authors:  N H Colburn
Journal:  Carcinogenesis       Date:  1980       Impact factor: 4.944

Review 2.  SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS.

Authors:  R K BOUTWELL
Journal:  Prog Exp Tumor Res       Date:  1964

3.  The effect of phorbol diesters on chicken embryo fibroblasts.

Authors:  P E Driedger; P M Blumberg
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

4.  Phenotypic expression of transformation: induction in cell culture by a phorbol ester.

Authors:  A Sivak; B L Van Duuren
Journal:  Science       Date:  1967-09-22       Impact factor: 47.728

5.  Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.

Authors:  R M Pruss; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells.

Authors:  N H Colburn; W F Bruegge; J R Bates; R H Gray; J D Rossen; W H Kelsey; T Shimada
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

7.  Effect of time and duration of exposure to 12-O-tetradecanoylphorbol-13-acetate on x-ray transformation of C3H 10T 1/2 cells.

Authors:  A R Kennedy; G Murphy; J B Little
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

8.  The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate enhances the proliferative response of Balb/c-3T3 cells to hormonal growth factors.

Authors:  C N Frantz; C D Stiles; C D Scher
Journal:  J Cell Physiol       Date:  1979-09       Impact factor: 6.384

9.  Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion.

Authors:  T J Slaga; A J Klein-Szanto; S M Fischer; C E Weeks; K Nelson; S Major
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.

Authors:  T J Slaga; S M Fischer; K Nelson; G L Gleason
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  56 in total

1.  Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2.

Authors:  Kangdong Liu; Chanmi Park; Shengqing Li; Ki Won Lee; Haidan Liu; Long He; Nak Kyun Soung; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-04-24       Impact factor: 4.944

2.  A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.

Authors:  Haidan Liu; Kangdong Liu; Zunnan Huang; Chan-Mi Park; N R Thimmegowda; Jae-Hyuk Jang; In-Ja Ryoo; Long He; Sun-Ok Kim; Naomi Oi; Ki Won Lee; Nak-Kyun Soung; Ann M Bode; Yifeng Yang; Xinmin Zhou; Raymond L Erikson; Jong-Seog Ahn; Joonsung Hwang; Kyoon Eon Kim; Zigang Dong; Bo-Yeon Kim
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

3.  Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs.

Authors:  Sergey N Fedorov; Oleg S Radchenko; Larisa K Shubina; Nadezhda N Balaneva; Ann M Bode; Valentin A Stonik; Zigang Dong
Journal:  Pharm Res       Date:  2006-12-05       Impact factor: 4.200

4.  Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Authors:  Kangdong Liu; Yong-Yeon Cho; Ke Yao; Janos Nadas; Dong Joon Kim; Eun-Jin Cho; Mee-Hyun Lee; Angelo Pugliese; Jishuai Zhang; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

5.  Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.

Authors:  Matthew R Young; Rajalakshmi Nair; Natalie Bucheimer; Preety Tulsian; Nicole Brown; Cristi Chapp; Tin-Chen Hsu; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

7.  Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.

Authors:  Hideya Mizuno; Yong-Yeon Cho; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-01       Impact factor: 4.784

8.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.

Authors:  C Huang; W Y Ma; Z Dong
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

9.  A transforming activity not detected by DNA transfer to NIH 3T3 cells is detected by JB6 mouse epidermal cells.

Authors:  N H Colburn; M I Lerman; G A Hegamyer; T D Gindhart
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

10.  Tumor-promoter-resistant cells lack trisialoganglioside response.

Authors:  L Srinivas; T D Gindhart; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.